2 March 2017
DETAILS
INEOS Oxide today announced that,
following clearance by the European Commission,
it has completed the acquisition
of Arkema’s Oxo alcohol business,
which included the acquisition
of Arkema’s stake in Oxochimie,
the Joint Venture at Lavéra
between INEOS and Arkema, producing
butryaldehyde and
oxo alcohols (butanol and 2-ethyl hexanol).
Oxochimie is a Joint Venture
at Lavéra, France and
is not part of the INEOS Group Holdings SA group.
Oxochimie produced butanols, 2-ethyl hexanol
and oxoaldehydes on behalf of its parent companies
that Arkema and INEOS marketed independently.
Graham Beesley,
CEO INEOS Oxide
“We are very pleased to have completed
the acquisition.
Oxo alcohols are a core business
for INEOS Oxide, both supplying
the European and global markets
and supporting the manufacturing of our fast
growing downstream intermediates businesses.
We look forward to integrating
theOxochimie joint venture
and growing our global market presence
in oxo alcohols, aldehydes & derivatives.”
For Further information contact:
Richard Longden
Phone: +41 21 807 0740
WWW.CHEMWINFO.COM BY KHUN PHICHAI
